These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15754170)

  • 1. Extending the clinicopathological spectrum of neurofilament inclusion disease.
    Josephs KA; Uchikado H; McComb RD; Bashir R; Wszolek Z; Swanson J; Matsumoto J; Shaw G; Dickson DW
    Acta Neuropathol; 2005 Apr; 109(4):427-32. PubMed ID: 15754170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study.
    Yokota O; Tsuchiya K; Terada S; Ishizu H; Uchikado H; Ikeda M; Oyanagi K; Nakano I; Murayama S; Kuroda S; Akiyama H
    Acta Neuropathol; 2008 May; 115(5):561-75. PubMed ID: 18080129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study original using alpha-internexin immunohistochemistry.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2006; 25(5):209-15. PubMed ID: 17007442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
    Uchikado H; Shaw G; Wang DS; Dickson DW
    Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.
    Cairns NJ; Uryu K; Bigio EH; Mackenzie IR; Gearing M; Duyckaerts C; Yokoo H; Nakazato Y; Jaros E; Perry RH; Arnold SE; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2004 Sep; 108(3):213-23. PubMed ID: 15170578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis.
    Mackenzie IR; Feldman H
    Clin Neuropathol; 2004; 23(4):183-93. PubMed ID: 15328884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study.
    Mackenzie IR; Feldman H
    Acta Neuropathol; 2004 Apr; 107(4):336-40. PubMed ID: 14745570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.
    Molina-Porcel L; Lladó A; Rey MJ; Molinuevo JL; Martinez-Lage M; Esteve FX; Ferrer I; Tolosa E; Blesa R
    Arch Neurol; 2008 Feb; 65(2):272-5. PubMed ID: 18268200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.
    Armstrong RA; Cairns NJ
    J Neural Transm (Vienna); 2007; 114(4):451-6. PubMed ID: 17109074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease.
    Krim E; Vital A; Macia F; Yekhlef F; Tison F
    Mov Disord; 2005 Feb; 20(2):200-4. PubMed ID: 15382212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the pathological changes in the temporal lobe of patients with a novel neurofilamentopathy: neurofilament inclusion disease (NID).
    Cairns NJ; Armstrong RA
    Clin Neuropathol; 2004; 23(3):107-12. PubMed ID: 15200288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous inclusions in neurofilament inclusion disease.
    Uchikado H; Li A; Lin WL; Dickson DW
    Neuropathology; 2006 Oct; 26(5):417-21. PubMed ID: 17080718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
    Cairns NJ; Grossman M; Arnold SE; Burn DJ; Jaros E; Perry RH; Duyckaerts C; Stankoff B; Pillon B; Skullerud K; Cruz-Sanchez FF; Bigio EH; Mackenzie IR; Gearing M; Juncos JL; Glass JD; Yokoo H; Nakazato Y; Mosaheb S; Thorpe JR; Uryu K; Lee VM; Trojanowski JQ
    Neurology; 2004 Oct; 63(8):1376-84. PubMed ID: 15505152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of neuronal degeneration of multiple system atrophy].
    Yoshida M; Sone M
    Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.